Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment - Wikidata - awgldk - TriplyDB

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

http://www.wikidata.org/entity/Q34002674

about

Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice.Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.Phase II drugs that are currently in development for the treatment of cachexia.Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.Update on Management of Cancer-Related Cachexia.The Influence of Ghrelin on the Development of Dextran Sodium Sulfate-Induced Colitis in Rats Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease Sex Differences in Muscle Wasting.

P2860

Q26739709-7E34BEE9-04D9-4C21-8D92-2342ABF50014 Q28079897-0FD02B3E-F5B6-4627-8DC9-10D29D0994C6 Q36092855-7C3FE856-E6D7-4FB7-AB56-60C6F5F81C2A Q37320958-98003821-7EBC-4580-B61A-C73371FD0FCD Q38233278-64DC15A3-A8AC-40FB-8EC2-09132F625E24 Q38832450-4549FA65-D0CB-42B0-9290-EB6C15823667 Q38990581-43C15767-C110-4E59-BC39-7AA8C14765D7 Q42122768-2316D5CE-2F2D-4A26-B34C-4269FF6DA154 Q42376081-417B463B-F327-4543-919A-BEB777C13B4D Q42577971-EFA859C0-10FC-492C-8636-2134E4EC44EF Q47311543-E65D9ED0-F717-4F86-8EED-607F16428271

P2860

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

http://www.wikidata.org/entity/Q34002674

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@ast

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@en

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@nl

type

label

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@ast

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@en

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@nl

prefLabel

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@ast

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@en

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@nl

P1433

Q34002674-5681C811-4AE1-4FA6-ACB6-21D382FD6D68

P1476

Q34002674-64495D75-5A9C-431A-B5C7-A94C54636514

P2093

Q34002674-36AC968B-7E5F-4E8D-AFEF-B2C2E3DB8346

Q34002674-B73CC014-F52A-403E-A3AC-0DD858C221C5

Q34002674-E0CC6F14-093D-4602-B61A-EE9EAE8942B7

P2860

Q34002674-0CD72505-7636-4504-8BDF-4A167D94AC9C

Q34002674-1C96013C-D4A1-47F5-A3BD-D7546A04920C

Q34002674-24AF8D42-F146-4AA8-A0A2-5B4FBFE2CC31

Q34002674-24DF5580-391A-4556-A088-7E86906178B3

Q34002674-2A05C8E6-E10C-49CA-A595-9314BF8384BC

Q34002674-2B00E421-3468-42B2-B094-2A2D6C5CD0E2

Q34002674-35541490-ECAC-46E9-8714-BF5DEF41F3D2

Q34002674-365A0A90-9F78-4F7E-A0A4-EE0221CBC6C6

Q34002674-4DC39E5E-B650-4ED5-A9FD-CD7E304FB650

Q34002674-4E1C8979-5204-4373-A080-B9F95417B36B

P304

Q34002674-B51AAEFC-E23D-48E3-91EC-872EFCB786D8

P31

Q34002674-27AEADFA-221D-402C-8B60-987C6C88BFD0

P356

Q34002674-27A8595B-CE5D-497C-A745-27F15429998B

P433

Q34002674-F186F1D4-C922-48A0-8392-38B06A54BF31

P478

Q34002674-EAD6FB58-48EF-45E8-B0AB-AA9C07E704BB

P577

Q34002674-75558A6E-F66D-42D0-A944-8DE3C19BA4FA

P698

Q34002674-8BE7C112-EA64-4D06-ADE3-0A5BCC2F08EE

P932

Q34002674-73B0092A-81B5-4BE1-867F-09169CDAF0DA

P356

SPC.0000000000000012

P1433

Current Opinion in Supportive and Palliative Care

P1476

Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment

@en

P2093

Ji-an Chen

http://www.w3.org/2001/XMLSchema#string

Jose M Garcia

http://www.w3.org/2001/XMLSchema#string

Sumbul Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

A receptor in pituitary and hypothalamus that functions in growth hormone release

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.

Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells.

Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.

Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.

P304

368-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/SPC.0000000000000012

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24145681

http://www.w3.org/2001/XMLSchema#string

P932

4121852

http://www.w3.org/2001/XMLSchema#string